Natural Health Trends Corp
NHTCNasdaqCIK 912061Consumer discretionaryFiscal year ends Dec 31
Reports and events: 251 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2809:20 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001437749-26-033713 |
| 2026-10-2809:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033711 |
| 2026-07-2909:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-024770 |
| 2026-07-2909:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024763 |
| 2026-05-0714:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-015500 |
| 2026-04-2909:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-013744 |
| 2026-04-2909:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-013743 |
| 2026-03-2414:28 ET | DEF 14A | Proxy statementPeriod 2026-05-07 | 0001437749-26-009523 |
| 2026-03-2412:00 ET | DEF 14A | Proxy statementPeriod 2026-05-07 | 0001437749-26-009522 |
| 2026-02-2013:45 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-004876 |
| 2026-02-1813:25 ET | SCHEDULE 13D | Ownership report, active investor | 0001299658-26-000002 |
| 2026-02-1716:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004352 |
| 2026-02-0409:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-002881 |
| 2025-11-0509:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033153 |
| 2025-11-0509:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033150 |
| 2025-07-3009:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-023873 |
| 2025-07-3009:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-023869 |
| 2025-05-0614:04 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-014718 |
| 2025-04-3009:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-013645 |
| 2025-04-3009:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-013643 |
| 2025-04-0211:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-010551 |
| 2025-03-2412:00 ET | DEF 14A | Proxy statementPeriod 2025-05-06 | 0001437749-25-008890 |
| 2025-03-1317:08 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-007552 |
| 2025-02-2113:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-004700 |
| 2025-02-0509:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-002836 |
| 2024-10-3009:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-032546 |
| 2024-10-3009:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-032544 |
| 2024-07-3109:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-024000 |
| 2024-07-3109:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-023999 |
| 2024-05-1415:00 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-016566 |
| 2024-05-0109:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-014082 |
| 2024-05-0109:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014080 |
| 2024-04-1916:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-012553 |
| 2024-04-1615:58 ET | SC 13D/A | Ownership report, active investor, amended | 0001437749-24-012176 |
| 2024-04-0112:00 ET | DEF 14A | Proxy statementPeriod 2024-05-14 | 0001437749-24-010241 |
| 2024-02-2812:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-005850 |
| 2024-02-0709:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-003298 |
| 2023-11-0109:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-029676 |
| 2023-11-0109:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-029675 |
| 2023-08-0209:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-021562 |
| 2023-08-0209:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-021560 |
| 2023-05-1614:00 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-014762 |
| 2023-05-0309:20 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-012208 |
| 2023-05-0309:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-012205 |
| 2023-04-0311:01 ET | DEF 14A | Proxy statementPeriod 2023-05-16 | 0001437749-23-009025 |
| 2023-03-0316:00 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-005365 |
| 2023-02-1018:27 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001437749-23-002923 |
| 2023-02-0809:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-23-002741 |
| 2022-11-2511:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-22-028062 |
| 2022-11-0209:20 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001437749-22-025471 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:27 ET. Listed shows no prices and gives no investment advice.